CYTK

Cytokinetics INC

+$923.4M

Net Activity

Institutions Holding

446

Popularity Rank

#1270

Avg Weight

0.40%

Total Value

$10.3B

Ownership Trend

446 institutions currently hold CYTK, with 255 net buyers and 198 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

198

Net Buying Institutions

255

Key Holders

Key Holders

Top 5 by Value

TR
T. Rowe Price Investment Management, Inc.
$1.2B
BI
BlackRock, Inc.
$1.1B
FL
FMR LLC
$706.8M
WM
Wellington Management Group LLP
$527.9M
VP
Vanguard Portfolio Management LLC
$385.2M

Top 5 by Conviction

RP
Royalty Pharma Sub-Manager, LLC
37.40%
IH
Integral Health Asset Management, LLC
8.20%
IC
Ikarian Capital, LLC
6.65%
MA
Melqart Asset Management (UK) Ltd
5.48%
NP
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
3.69%
View all 446 holding institutions

Quarterly Activity

Recent Activity

+$5.3B

Total Buy Value

$4.7B

Total Sell Value

New buy71
Trim136
Add184
Sold out62

255

Net Buyers

198

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

5

Filings (90d)

$10.99M

Total Est. Value

132K shares

Planned Shares

Last Filed 2026-07-07
FilerFiling DateEst. Value
FADY MALIK2026-07-07$2.10M
ROBERT BLUM2026-07-01$4.47M
Lee Sung2026-06-29$781K
Lee Sung2026-06-26$541K
Lee Sung2026-06-24$3.10M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

0

Active 5%+ Holders

Data as of 2026-07-08
Reporting PersonTypeFiling Date% of Class
FMR LLC13G/A2026-07-083.9%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CYTOKINETICS INC (CYTK)?
Major stakeholders currently include T. Rowe Price Investment Management, Inc. ($1.2B), BlackRock, Inc. ($1.1B), FMR LLC ($706.8M). Based on the latest 13F filings, there are a total of 446 tracked investment funds and institutions maintaining positions in CYTK.
What is the overall institutional sentiment toward CYTK recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $923.4M, driven by 255 managers accumulating shares while 198 reduced their exposure.
Which institutions have been selling or reducing their CYTK positions?
In the latest period, 136 funds trimmed their holdings, and 62 managers completely exited their positions. The aggregate reported sell value was $4.7B.
Are there any notable investors adding CYTK to their portfolios?
Yes, buying activity remains notable. 71 institutions opened new positions in {ticker}, and 184 existing holders added to their shares. The total reported buy value for the quarter amounted to $5.3B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

365 institutions currently hold both CYTK and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

380 institutions currently hold both CYTK and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

357 institutions currently hold both CYTK and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail